Concerning COVID-19, Tony Fauci's NIH tells doctors to "sit back and watch patients die."
Mark Crispin Miller
NIH Panel Issues Guidelines for COVID-19 Treatment
Diana Swift
April 22, 2020
Dr. Maria Rivero15 minutes agoWhat about IV Vitamin C? What about medical ozone? This guideline is worse than nothing.
Victor Ilog16 minutes agoThis guidance isn’t guidance at all.
Not sure what the point of this article was. It appears the only purpose of the article was for NIH to go on record NOT recommending the use of combination hydroxychloroquine/azithromycin. Was there any other point or purpose?
So as of today, the guidance from NIH is to sit back and watch patients die. These are supposed to be the smartest people in the room? Thanks for nothing...
Dr. Raymond Lodise27 minutes agoAlho it's a useless article, one thing: you really can't make a mistake if it makes sense to you. So in that regard it is helpful.
Dr. Johnny Peet50 minutes agoSo they recommended no treatments at all. Thanks so much for nothing.
Dr. Paul Dickson54 minutes agoWorthless frigging article, with absolutely no new information. It is useless, unless you can publish something to help those treat these patients, then SHUT UP, STFU!!!
Dr. Matthew Klein55 minutes agoWas there a reason to publish this piece, missing more information than it states?
Dr. Benton Zwart1 hour agoDisappointing. This article can be summarized in 3 words: "We Don't Know"
No mention of the Northern California Internist who has reported a favorable case series using Duoneb+Mucomyst (Ipratropium bromide/salbutamol +Acetylcysteine) nebulizer.Dr. Stacy Childs1 hour agoIt is not only useless but possibly harmful to publish this guideline as it is not a guideline at all. It implies we know nothing so do nothing other than wait it out. Until results of clinical trials start filtering in, you should print nothing except positive or negative anecdotal results. If I get this virus, you better believe I will be taking at least Hydroxychloraquin, zinc, and possibly Z-pac while monitoring my ECG.
Dr. derek cornelius1 hour agoDon't do anything; don't try anything. God forbid you try something on someone that is about to die. That would be unethical.
Dr. anastasios pappas1 hour agoNeed to monitor serial ferritin to see if a patient is going towards more cytokine storm syndrome requiring cytokine inhibitors versus those more in the "influenza like" world that need more antibiotics
Dr. Robert Ross1 hour agoDefinitely useless information, why waste your time writing or reading.
Dr. anastasios pappas1 hour agoIf the article does not reference cytokine storm syndrome, etc. It is lacking in knowledge of COVID -19.
Simply utilize the Ireland protocol published March 20th.
Mikhail Shvarts2 hours agoAnother “useful” article about covid19 and treatment options. Basically “nothing is recommended or not recommended”. Why even publish this.
On that note here are some things I’ve done and seen some success with my patients. Feel free to add what works with yours.
1) consider anticoagulation especially if ferritin and d-dimer are significantly elevated
2) they tend to go into renal failure rather quickly. Unclear as to the true mechanism involved or maybe just dehydration from fevers and tachypnea.....so hydrate aggressively....haven’t overloaded anyone yet
3) add additional coverage if using azithromycin....alone it is not enough for severe disease. Fine for moderate to mild cases.
Dr. michael Assumani3 hours agoIs it possible to check chest X-ray in 3D ?this clearly show that the virus blocks the alveoli and causes a sort of pulmonary embolism with acute respiratory distress,this is the reason why most of the above mentioned treatment are not very effective including intubation.I will humbly suggest we consider other treatments.Humbly
In the face of the rapidly evolving COVID-19 pandemic and the absence of FDA-approved treatments, the National Institutes of Health (NIH) has issued "living" treatment guidelines. The recommendations will be updated online as new data from peer-reviewed publications and other authoritative information become available.A multidisciplinary panel of 30 scientific, clinical, and government experts started working on the guidelines in late March. They released the first iteration online yesterday. Other groups, including the Infectious Diseases Society of America, have previously provided treatment summaries or recommendations.The current NIH guidelines were by compiled by working groups with expertise in different areas. As per the standard process for establishing clinical guidelines, these groups systematically reviewed all relevant, credible information and scientific publications and made three levels of recommendation of varying strength on the basis of strength of evidence from randomized and nonrandomized clinical trials, well-designed observational studies, and expert opinion."There are not a lot of data out there to guide us, so we had to rely a lot on expert opinion," said panel co-chair Roy M. Gulick, MD, MPH, a professor of medicine and chief of infectious diseases at Weill Cornell Medicine in New York City. "We have to face the reality that we don't yet have the controlled clinical data we need in order to say whether something works. But we asked ourselves whether guidelines were needed now, and we decided that we do need to provide guidance for clinicians facing critical patients and wanting to do something to help them.""At this moment the main sentiment we want to convey is that there are no licensed treatments for COVID-19, but there are a lot of good ideas. And the sooner we can test them, the sooner we can update the guidelines," panel co-chair H. Clifford Lane, MD, clinical director of the National Institute of Allergy and Infectious Diseases, told Medscape Medical News.